These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

749 related articles for article (PubMed ID: 19609891)

  • 1. Omega-3 dietary supplements and the risk of cardiovascular events: a systematic review.
    Marik PE; Varon J
    Clin Cardiol; 2009 Jul; 32(7):365-72. PubMed ID: 19609891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease.
    Abdelhamid AS; Brown TJ; Brainard JS; Biswas P; Thorpe GC; Moore HJ; Deane KH; Summerbell CD; Worthington HV; Song F; Hooper L
    Cochrane Database Syst Rev; 2020 Feb; 3(3):CD003177. PubMed ID: 32114706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease.
    Abdelhamid AS; Brown TJ; Brainard JS; Biswas P; Thorpe GC; Moore HJ; Deane KH; AlAbdulghafoor FK; Summerbell CD; Worthington HV; Song F; Hooper L
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD003177. PubMed ID: 30521670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease.
    Abdelhamid AS; Brown TJ; Brainard JS; Biswas P; Thorpe GC; Moore HJ; Deane KH; AlAbdulghafoor FK; Summerbell CD; Worthington HV; Song F; Hooper L
    Cochrane Database Syst Rev; 2018 Jul; 7(7):CD003177. PubMed ID: 30019766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: a meta-analysis of randomized, double-blind, placebo-controlled trials.
    Kwak SM; Myung SK; Lee YJ; Seo HG;
    Arch Intern Med; 2012 May; 172(9):686-94. PubMed ID: 22493407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eicosapentaenoic Acid for Cardiovascular Events Reduction- Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.
    Yokoyama Y; Kuno T; Morita SX; Slipczuk L; Takagi H; Briasoulis A; Latib A; Bangalore S; Heffron SP
    J Cardiol; 2022 Nov; 80(5):416-422. PubMed ID: 35914996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of fish oil on arrhythmias and mortality: systematic review.
    León H; Shibata MC; Sivakumaran S; Dorgan M; Chatterley T; Tsuyuki RT
    BMJ; 2008 Dec; 337():a2931. PubMed ID: 19106137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. n-3 fatty acids and cardiovascular events after myocardial infarction.
    Kromhout D; Giltay EJ; Geleijnse JM;
    N Engl J Med; 2010 Nov; 363(21):2015-26. PubMed ID: 20929341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omega-3 Fatty Acids and Cardiovascular Disease: An Updated Systematic Review.
    Balk EM; Adams GP; Langberg V; Halladay C; Chung M; Lin L; Robertson S; Yip A; Steele D; Smith BT; Lau J; Lichtenstein AH; Trikalinos TA
    Evid Rep Technol Assess (Full Rep); 2016 Aug; (223):1-1252. PubMed ID: 30307737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omega-3 polyunsaturated fatty acids supplementation and cardiovascular outcomes: do formulation, dosage, and baseline cardiovascular risk matter? An updated meta-analysis of randomized controlled trials.
    Casula M; Olmastroni E; Gazzotti M; Galimberti F; Zambon A; Catapano AL
    Pharmacol Res; 2020 Oct; 160():105060. PubMed ID: 32634581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk stratification by the "EPA+DHA level" and the "EPA/AA ratio" focus on anti-inflammatory and antiarrhythmogenic effects of long-chain omega-3 fatty acids.
    Rupp H; Wagner D; Rupp T; Schulte LM; Maisch B
    Herz; 2004 Nov; 29(7):673-85. PubMed ID: 15580322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks: Meta-analysis of 10 Trials Involving 77 917 Individuals.
    Aung T; Halsey J; Kromhout D; Gerstein HC; Marchioli R; Tavazzi L; Geleijnse JM; Rauch B; Ness A; Galan P; Chew EY; Bosch J; Collins R; Lewington S; Armitage J; Clarke R;
    JAMA Cardiol; 2018 Mar; 3(3):225-234. PubMed ID: 29387889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial.
    Nicholls SJ; Lincoff AM; Garcia M; Bash D; Ballantyne CM; Barter PJ; Davidson MH; Kastelein JJP; Koenig W; McGuire DK; Mozaffarian D; Ridker PM; Ray KK; Katona BG; Himmelmann A; Loss LE; Rensfeldt M; Lundström T; Agrawal R; Menon V; Wolski K; Nissen SE
    JAMA; 2020 Dec; 324(22):2268-2280. PubMed ID: 33190147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: evidence from a meta-analysis of randomized controlled trials.
    Martins JG
    J Am Coll Nutr; 2009 Oct; 28(5):525-42. PubMed ID: 20439549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statin Use Mitigate the Benefit of Omega-3 Fatty Acids Supplementation-A Meta-Regression of Randomized Trials.
    Sethi A; Bajaj A; Khosla S; Arora RR
    Am J Ther; 2016; 23(3):e737-48. PubMed ID: 25036814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eicosapentaenoic Acid Versus Docosahexaenoic Acid as Options for Vascular Risk Prevention: A Fish Story.
    Singh S; Arora RR; Singh M; Khosla S
    Am J Ther; 2016; 23(3):e905-10. PubMed ID: 25828517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular disease prevention and treatment.
    von Schacky C
    Prostaglandins Leukot Essent Fatty Acids; 2009; 81(2-3):193-8. PubMed ID: 19520557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. n-3 fatty acids and cardiovascular disease.
    Breslow JL
    Am J Clin Nutr; 2006 Jun; 83(6 Suppl):1477S-1482S. PubMed ID: 16841857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis.
    Rizos EC; Ntzani EE; Bika E; Kostapanos MS; Elisaf MS
    JAMA; 2012 Sep; 308(10):1024-33. PubMed ID: 22968891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of omega-3 fatty acids on coronary revascularization and cardiovascular events: a meta-analysis.
    Dinu M; Sofi F; Lotti S; Colombini B; Mattioli AV; Catapano AL; Casula M; Baragetti A; Wong ND; Steg PG; Ambrosio G
    Eur J Prev Cardiol; 2024 Nov; 31(15):1863-1875. PubMed ID: 38869144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.